You have successfully logged out.

Hello !
Logout

Particulate Contamination in Paediatrics & Neonatology

What is Particulate Contamination

Particulate contamination is the unintended presence of extraneous, mobile, and undissolved particles in parenteral solutions.3, 4

Causes of particulate contamination are primarily drugs that are present in various containers (e.g., vials, ampoules, pre-filled containers, and premixed solutions). Many types of particulate contamination derive from glass, plastic, rubber and/or undissolved solids. These particles can vary in size and may cause serious damage to neonatal and paediatric patients. 

 

Medical Professional

This information is meant for medical professionals only. Please confirm that you are a medical professional before accessing the information.

Confirm Yes, I am a health care professional. Cancel No, I am not a health care professional.
Did you know that is estimated that 1 Mio. particles per day are infused in an ICU setting?1,2

Highlight Safety Products

Highlight Safety Products

Risk Prevention in Pediatrics & Neonatology

[1] Mehrkens HH, Klaus E, Schmitz JE. Possibilities of material contamination due to additional injections. Klin Anasthesiol Intensivther. 1977;14:106-13.

[2] Walpot H, Franke RP, Burchard WG, Agternkamp C, Müller FG, Mittermayer C, Kalff G. Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy. 1. Energy dispersion electron images in the scanning electron microscope-REM/EDC. Anasthesist. 1989;38(10):544-8.

[3] Werner BP, Winter G. (2015) Particle contamination of parenteralia and in-line filtration of proteinaceous drugs. Int J Pharm;496(2):250-67

[4] Doessegger L, Mahler HC, Szczesny P, Rockstroh H, Kallmeyer G, Langenkamp A, Herrmann J, Famulare J. (2012) The potential clinical relevance of visible particles in parenteral drugs. J Pharm Sci; 101(8): 2635-44

[5] Jack T. Micro Particles Contamination. Innocent Bystander or Real Threat? 2012 (Presentation: „_Micro Particles Contamination_Jack_MHH_2012“).

[6] Boehne M, Jack T, Köditz H, Seidemann K, Schmidt F, Abura M, Bertram H, Sasse M. In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trial. BMC Pediatr. 2013;13:21.

[7] Puntis JW, Wilkins KM, Ball PA, Rushton DI, Booth IW. Hazards of parenteral treatment: do particles count? Arch Dis Child 1992 Dec;67(12):1475–7.

[8] Breaux CW, Duke D, Georgeson KE, Mestre JR. Calcium phosphate crystal occlusion of central venous catheters used for total parenteral nutrition in infants and children: prevention and treatment. J Pediatr Surg 1987 Sep;22(9):829–32.

[9] Bradley JS, Wassel RT, Lee L, Nambiar S. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics 2009 Apr;123(4):e609–13.

[10] Monte SV, Prescott WA, Johnson KK, Kuhman L, Paladino JA. Safety of ceftriaxone sodium at extremes of age. Expert Opin Drug Saf 2008 Sep;7(5):515–23.

[11] Perez M, Maiguy-Foinard A, Barthélémy C, Décaudin B, Odou P. Particulate Matter in Injectable Drugs: Evaluation of Risks to Patients. Pharmaceutical Technology in Hospital Pharmacy 2016;1(2):91-103.

[12] Van Lingen RA, Baerts W, Marquering ACM, Rujis GJHM. The use of in-line filtration in sick newborn infants. Acta paediatrica 2004; 93:1-5.

[13] Heyman S. Toxicity and safety factors associated with lung perfusion studies with radiolabeled particles. J Nucl Med Off Publ Soc Nucl Med 1979 Oct;20(10):1098–9.

[14] Lofthus RM, Srebnik HH. The physical dimensions of the human neonatal cardiovascular system. J Biomech Eng 1987 Nov;109(4):336–9.

[15] Bethune K Allwood M, Grainger C, Wormleighton C; British Pharmaceutical Nutrition Group Working Party. (2001) Use of filters during the preparation and administration of parenteral nutrition: position paper and guidelines prepared by a British pharmaceutical nutrition group working party. Nutrition;17(5):403-8.

[16] Virlouvet AL, Pansiot J, Toumazi A et al. In-line filtration in very preterm neonates: a randomized controlled trial. Sci Rep 2020; 10(5003).

[17] Jack T, Boehne M, Brent BE, Hoy L, Köditz H, Wessel A, Sasse M. In-line filtration reduces severe complications and length of stay on pediatric intensive care unit: a prospective, randomized, controlled trial. Intensive Care Med. 2012; 38:1008–1016.